Scott Peters
Comptroller/Controller/Auditor bij PLIANT THERAPEUTICS, INC.
Profiel
Scott Peters is currently the Vice President-Finance & Controller at Pliant Therapeutics, Inc. Prior to his current position, he worked at Alexion Pharmaceuticals, Inc. as the Executive Director & Controller from 2013 to 2021.
Mr. Peters completed his undergraduate degree at the University of California, Santa Barbara.
Actieve functies van Scott Peters
Bedrijven | Functie | Begin |
---|---|---|
PLIANT THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 01-02-2021 |
Eerdere bekende functies van Scott Peters
Bedrijven | Functie | Einde |
---|---|---|
ALEXION PHARMACEUTICALS, INC. | Director/Board Member | 01-02-2021 |
Opleiding van Scott Peters
University of California, Santa Barbara | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
PLIANT THERAPEUTICS, INC. | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
Alexion Pharmaceuticals, Inc.
Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |